Microneedle-Mediated Transcutaneous Immunization: Potential in Nucleic Acid Vaccination

Area of Science:

• Biotechnology
• Vaccinology
• Nanotechnology

Background:

• Nucleic acid vaccines offer design flexibility but require efficient delivery systems.
• Traditional syringe vaccination faces challenges with patient compliance and cost.
• Microneedles (MNs) present a promising solution for painless and efficient vaccine delivery.

Purpose of the Study:

• To review the current research status of microneedle (MN) vaccines.
• To summarize advancements in MN-mediated nucleic acid vaccination.
• To discuss challenges and future directions for clinical translation.

Main Methods:

• Review of existing literature on microneedle vaccine technology.
• Analysis of studies demonstrating MN feasibility for vaccine delivery.
• Synthesis of data on improvements in MN-mediated nucleic acid delivery.

Main Results:

• Microneedles effectively breach the stratum corneum for enhanced vaccine delivery to the epidermis and dermis.
• Preclinical and clinical studies support the feasibility of MN-mediated vaccination.
• Significant potential exists for MNs in delivering nucleic acid vaccines.

Conclusions:

• Microneedle technology provides an innovative and efficient strategy for vaccine delivery, particularly for nucleic acid vaccines.
• Further research and development are needed to address challenges for widespread clinical adoption.
• MNs represent a significant advancement in overcoming traditional vaccination limitations.